Health Trials

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

ConditionsAnkylosing SpondylitisAutoimmune DiseaseCrohn DiseaseEnteropathic ArthritisEnteropathic SpondylitisInflammatory Bowel DiseaseMelanomaPsoriasisPsoriatic ArthritisReactive ArthritisRheumatoid ArthritisSystemic Lupus ErythematosusUlcerative Colitis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorM.D. Anderson Cancer Center

About this trial

This study learn how easily patients can use an educational tool that will be created for patients with melanoma and pre-existing autoimmune diseases who receive or will receive immune checkpoint inhibitor drugs. Patients will be asked their opinions about the design, accessibility, and content of the tool. Researchers will use the information collected to improve the educational materials that will help patients make future decisions about their treatment.

Eligibility criteria

Qualifiers

Diagnosis of melanoma

Diagnosis of pre-existing autoimmune disease

Inflammatory bowel disease

Diagnosis of Crohn's disease or ulcerative colitis by a gastroenterologist

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Best Practice
  • Educational Intervention
  • Interview
  • Questionnaire Administration
  • Survey Administration

Treatment groups

125 Participants
are divided into 3 treatment groups

Sponsors and collaborators

M.D. Anderson Cancer Center

Lead sponsor

National Cancer Institute (NCI)

Collaborator

Source ClinicalTrials.gov